Conducting cancer clinical trials in the COVID-19 era
Speaker: Gary Lyman
Gary Lyman discusses the effects of the coronavirus pandemic on various aspects of oncology clinical trials, from accrual to analysis, and highlights the need for robust research on COVID-19 and cancer.
22 May 2020: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.
Listen below or subscribe to this podcast on: